$63.22 0.4%
ANIP Stock Price vs. AI Score (Last 150 days)
Data gathered: July 16

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About ANI Pharmaceuticals

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada.

ANI Pharmaceuticals
Price $63.22
Target Price Sign up
Volume 151,890
Market Cap $1.33B
Year Range $48.72 - $69.69
Dividend Yield 0%
PE Ratio 39.27
Revenue per Employee $816,879
Industry Biotechnology

In the news

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q1 '24135M112M24M18M47M1.210
Q4 '23123M113M9.8M1.2M25M1.000
Q3 '23124M105M18M9.9M35M1.270
Q2 '23109M96M13M6.2M28M1.280
Q1 '2399M89M10M1.4M25M1.170

Insider Transactions View All

Cook Meredith filed to sell 58,981 shares at $64.9.
July 15 '24
Gassert Chad filed to sell 193,226 shares at $63.4.
July 2 '24
Shanmugam Muthusamy filed to sell 682,620 shares at $58.9.
June 24 '24
Shanmugam Muthusamy filed to sell 702,620 shares at $59.9.
June 20 '24
Shanmugam Muthusamy filed to sell 714,067 shares at $60.8.
June 20 '24

What is the Market Cap of ANI Pharmaceuticals?

The Market Cap of ANI Pharmaceuticals is $1.33B.

What is ANI Pharmaceuticals' PE Ratio?

As of today, ANI Pharmaceuticals' PE (Price to Earnings) ratio is 39.27.

How Many People Work at ANI Pharmaceuticals?

As of our latest update, ANI Pharmaceuticals employed approximately 601 people worldwide. However, it's important to note that ANI Pharmaceuticals' workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.

What is ANI Pharmaceuticals' revenue per employee?

$816,879. To calculate ANI Pharmaceuticals' revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.

What is the current stock price of ANI Pharmaceuticals?

Currently, the price of one share of ANI Pharmaceuticals stock is $63.22.

How can I analyze the ANIP stock price chart for investment decisions?

The ANIP stock price chart above provides a comprehensive visual representation of ANI Pharmaceuticals' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling ANI Pharmaceuticals shares. Our platform offers an up-to-date ANIP stock price chart, along with technical data analysis and alternative data insights.

Does ANIP offer dividends to its shareholders?

As of our latest update, ANI Pharmaceuticals (ANIP) does not offer dividends to its shareholders. Investors interested in ANI Pharmaceuticals should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of ANI Pharmaceuticals?

Some of the similar stocks of ANI Pharmaceuticals are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.